US ADDS MERCK PILL AS 2ND EASY-TO-USE DRUG AGAINST COVID-19 23 Dec 2021 Consulting, General, World The FDA’s authorization of molnupiravir comes one day after the agency cleared a competing drug from Pfizer. americans, covid19, fda, health, pfizer, record, us, variant Read more
